DEVELOPMENT OF RECOMBINANT ACE2-LIKE ENZYME PROTEIN FROM BACILLUS CEREUS AS A THERAPEUTIC AGENT FOR COVID-19 PATIENTS
SARS-CoV-2 infection can cause downregulation of ACE2, resulting in higher levels of pro-inflammatory Angiotensin II in the body. To overcome this, a therapy with recombinant human ACE2 protein (rhACE2) is needed to restore the body's homeostasis. However, the use of rhACE2 is expensive, so an...
Saved in:
| Main Author: | |
|---|---|
| Format: | Final Project |
| Language: | Indonesia |
| Online Access: | https://digilib.itb.ac.id/gdl/view/76446 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Institut Teknologi Bandung |
| Language: | Indonesia |